Cargando…
Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain
Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852275/ https://www.ncbi.nlm.nih.gov/pubmed/33532781 http://dx.doi.org/10.1101/2021.01.26.428356 |
_version_ | 1783645789211328512 |
---|---|
author | Tan, Timothy J.C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. |
author_facet | Tan, Timothy J.C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. |
author_sort | Tan, Timothy J.C. |
collection | PubMed |
description | Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major role, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, have not been elucidated. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that appear to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. Overall, our results advance fundamental understanding of the antibody response to SARS-CoV-2. |
format | Online Article Text |
id | pubmed-7852275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-78522752021-02-03 Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain Tan, Timothy J.C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. bioRxiv Article Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major role, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, have not been elucidated. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that appear to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. Overall, our results advance fundamental understanding of the antibody response to SARS-CoV-2. Cold Spring Harbor Laboratory 2021-01-27 /pmc/articles/PMC7852275/ /pubmed/33532781 http://dx.doi.org/10.1101/2021.01.26.428356 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Tan, Timothy J.C. Yuan, Meng Kuzelka, Kaylee Padron, Gilberto C. Beal, Jacob R. Chen, Xin Wang, Yiquan Rivera-Cardona, Joel Zhu, Xueyong Stadtmueller, Beth M. Brooke, Christopher B. Wilson, Ian A. Wu, Nicholas C. Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain |
title | Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain |
title_full | Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain |
title_fullStr | Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain |
title_full_unstemmed | Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain |
title_short | Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain |
title_sort | sequence signatures of two ighv3-53/3-66 public clonotypes to sars-cov-2 receptor binding domain |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852275/ https://www.ncbi.nlm.nih.gov/pubmed/33532781 http://dx.doi.org/10.1101/2021.01.26.428356 |
work_keys_str_mv | AT tantimothyjc sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT yuanmeng sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT kuzelkakaylee sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT padrongilbertoc sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT bealjacobr sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT chenxin sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT wangyiquan sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT riveracardonajoel sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT zhuxueyong sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT stadtmuellerbethm sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT brookechristopherb sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT wilsoniana sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain AT wunicholasc sequencesignaturesoftwoighv353366publicclonotypestosarscov2receptorbindingdomain |